Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-09-10 M&A Activity
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
M&A Activity 2009
M&A Activity Classification · 98% confidence The document text discusses the expiration of a tender offer (budkrigen) made by Kiwi Deposit to acquire a majority stake in Gudme Raaschou Vision A/S. It details the deadline passing without acceptance from the target company (Pantebrevsselskabet) and Kiwi Deposit's subsequent consideration of making a new bid or withdrawing. This content directly relates to a proposal or bid concerning a merger or takeover activity. Therefore, the most appropriate classification is 'M&A Activity' (TAR). The document is a news-style update regarding the status of a takeover bid, not a formal regulatory filing like a 10-K or a general regulatory announcement (RNS).
2009-09-10 English
M&A Activity 2009
M&A Activity
2009-09-10 Danish
M&A Activity 2009
M&A Activity
2009-09-08 Danish
M&A Activity 2009
M&A Activity Classification · 98% confidence The document text describes a specific corporate action: Kiwi Deposit Building Society increasing its takeover bid (bud) for a majority stake in Gudme Raaschou Vision A/S, in response to a competing bid. This involves an offer to acquire shares, which falls under corporate transactions, mergers, or takeovers. Based on the provided definitions, 'M&A Activity (Code: TAR)' is the most appropriate classification for announcements related to merger proposals or takeover bids. The document is a formal announcement detailing the revised offer price and timeline.
2009-09-08 English
M&A Activity 2009
M&A Activity
2009-09-07 Danish
M&A Activity 2009
M&A Activity Classification · 98% confidence The document is a formal announcement ("MEDDELELSE") addressed to the Danish stock exchange (NASDAQ OMX Copenhagen A/S). The content explicitly details the results of a mandatory takeover bid ("pligtmæssige købstilbud") made by one company to the shareholders of another (Gudme Raaschou Vision A/S). It specifies the offer price, the expiration date, and the final ownership percentage held by the bidder after the offer period concluded. This subject matter—a takeover bid and its outcome—falls directly under the definition of M&A Activity (Merger or Takeover). Therefore, the appropriate code is TAR.
2009-09-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.